| Literature DB >> 35379247 |
Emmelie Barenfeld1,2,3, Joanne M Fuller4,5, Sara Wallström4,5,6, Andreas Fors4,5,7, Lilas Ali4,5,8, Inger Ekman4,5,9.
Abstract
BACKGROUND: Process evaluations are useful in clarifying results obtained from randomised controlled trials (RCTs). Traditionally, the degree of intervention usage in process evaluations is monitored by measuring dose or evaluating implementation fidelity. From a person-centred perspective, such evaluations should be supplemented with patients' experiences of meaningful use, given that intervention use should be agreed upon between interested parties and tailored to each patient. This study aimed to elucidate patients' experiences of a remote person-centred care (PCC) intervention by deepening the understanding of, if, how and for whom the intervention contributed to meaningful use.Entities:
Keywords: COPD; Chronic condition; Chronic heart failure; Patient-centered; Patient-centred; Person-centered; Person-centred; Prevention; Process-evaluation; Tele-Health; Telemedicine; eHealth
Mesh:
Year: 2022 PMID: 35379247 PMCID: PMC8981820 DOI: 10.1186/s12913-022-07831-8
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Overview of functions in the remote PCC intervention
| Co-creation and follow-up of tailored health plans via structured telephone support |
| Access to their health plans on the digital platform |
| Writing their health plan |
| Invitation to family and friends to the digital platform |
| Rating symptoms and wellbeing and monitoring trend graphs of self-ratings |
| Daily access to health professionals via structured telephone support or the digital platform |
| Validated links about CHF and COPD and other useful health information sites |
Overview of data sources, data collection procedures and analysis in the quantitative and qualitative approaches
| Quantitative approach | Qualitative approach | ||
|---|---|---|---|
| Questionnaire | Written comments | Interviews | |
| Participated in the PROTECT trial intervention group | Purposeful sampling to capture heterogeneity across age, sex, educational level and e-support use | ||
| Diagnosed with COPD or CHF | |||
| Ability to understand written and spoken Swedish | |||
| Listed at one of the nine participating primary care centres in the PROTECT-trial | |||
| Self-ratings | Written comments | Face-to-face or telephone interviews | |
| Three questions | One question | One opening question | |
| Demographic questions | Interview guide with question areas | ||
| Probes | |||
| Descriptive statistics and logistic regression analyses | Content analysis | Content analysis | |
CHF Chronic Heart Failure, COPD Chronic Obstructive Pulmonary Disease, PROTECT = name of the evaluated remote PCC intervention
Participant characteristics and demographics
| Participants included in quantitative process evaluation | Not included | Participants providing written comments | Interviewees | ||
|---|---|---|---|---|---|
| Mean, years (SD) | 71.3 (9.2) | 70.2 (11.7) | .63 | 71.8 (10.0) | 71.4 |
| Median, years (min, max) | 72.5 (33–93) | 71.0 (42–90) | 72.5 (33–93) | 73 (57–81) | |
| Women (%) | 40 (46.5%) | 11 (45.8%) | 1.00 | 24 (54.5%) | 5 (41.7%) |
| Living alone (%) | 36 (41.9%) | 6 (25%) | 0.22 | 18 (40.9%) | 2 (16.7%) |
| CHF (%) | 34 (39.5%) | 8 (33.3%) | 0.21 | 12 (27.3%) | 1 (8.3%) |
| COPD (%) | 45 (52.3%) | 11 (45.8%) | 28 (63.6%) | 9 (75.0%) | |
| CHF and COPD (%) | 7 (8.1%) | 5 (20.8%) | 4 (9.1%) | 2 (16.7%) | |
| Compulsory (%) | 28 (32.6%) | 10 (41.7%) | 0.24 | 14 (3.,8%) | 4 (33.3%) |
| Secondary school (%) | 17 (19.8%) | 8 (33.3%) | 9 (20.5%) | 4 (33.3%) | |
| Vocational college (%) | 22 (25.6%) | 3 (12.5%) | 10 (22.7%) | 1 (8.3%) | |
| University (%) | 19 (22.1%) | 3 (12.5%) | 11 (25.0%) | 3 (25.0%) | |
| Good or better (%) | 51 (60,0%) | 6a (40%) | 0.22 | 27 (61.4%) | 9 (75,0%) |
| Number of phone calls (median, min–max) | 3, (0–6) | 3, (0–4) | 1.00 | 4, (1–6) | 3, (2–5) |
| Used digital platform functions (%) | 60 (69.8%) | 16 (66.7%) | 0.81 | 32 (72.7%) | 11 (91.7%) |
amissing n = 10
CHF Chronic Heart Failure, COPD Chronic Obstructive Pulmonary Disease, SD Standard Deviation
Overview of ratings on meaningful use for the overall intervention and specific intervention functions, n = 86
| Overall intervention | Structured telephone support | Digital platform functions | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Phone calls | Direct-dial contact | Ratings | Follow trend graphs | Direct messaging | Access to | Write own | Validated CHF | ||
| 53(63.9%)a | 58(69.9%)a | 26(31.3%)a | 26(31.3%)a | 8(9.6%)a | 18(21.7%)a | 12(14.5%)a | 6(7.2%)a | 13(15.7%)a | |
| CHF | 18(58.1%)a | 21(63.6%)b | 10(30.3%)b | 9(27.3%)b | 1(3.0%)b | 4(12.1%)b | 3(9.1%)b | 2(6.1%)b | 2(6.1%)b |
| COPD | 34(75.6%) | 33(76.7%)c | 13(30.2%)c | 16 (37.2%)c | 4(14.0%)c | 14(32.6%)c | 9(20.9%)c | 4(9.3%)c | 8(18.6%)c |
| CHF & COPD | 1(14.3%) | 4(57.1%) | 0(0.0%) | 1(14.3%) | 1(14.3%) | 0(0.0%) | 0(0.0%) | 0(0.0%) | 3(42.9%) |
| Living alone | 22(66.7%)a | 27(79.4%)b | 12(35.3%)b | 16(47.1%)b | 5(14.7%)b | 11(32.4%)b | 8(23.5%)b | 4(11.8%)b | 7(20.6%)b |
| Married/Partner | 31(62.0%) | 31(63.3%)c | 11(22.4%)c | 10(20.4%)c | 3(6.1%)c | 7(14.3%)c | 4(8.2%)c | 2(4.1%)c | 6(12.2%)c |
| Male | 26(59.1%)c | 29(64.4%)b | 7(15.6%)b | 14(31.1%)b | 4(8.9%)b | 7(15.6%)b | 5(11.1%)b | 3(6.7%)b | 8(17.8%)b |
| Female | 27(69.2%)b | 29(76.3%)c | 16(42.1%)c | 12(31.6%)c | 4(10.5%)c | 11(28.9%)c | 7(18.4%)c | 3(7.9%)c | 5(13.2%)c |
| Good | 34(66.7%) | 34(68.0%)b | 9(18.0%)b | 15(30.0%)b | 5(10.0%)b | 12(24.0%)b | 8(16.0%)b | 6(12.0%)b | 10(20.0%)b |
| Poor | 19(61.3%)a | 23(71.9%)c | 13(40.6%)c | 10(29.0%)c | 3(9.4%)c | 6(18.8%)c | 3(9.4%)c | 0(0.0%)c | 3(9,4%)c |
| < Secondary | 30(71.4%)a | 27(67.5%)c | 11(25.6%)c | 12(27.9%)c | 4(9.3%)c | 11(25,6%)c | 7(16,3%)c | 1(2,3%)c | 6(14,0%)c |
| | 23(56,1%) | 31(72,1%)b | 12(30,0%)b | 14(35,0%)b | 4(10%)b | 7(17.5%)b | 5(12.5%)b | 5(12.5%)b | 7(17.5%)b |
| | 39(69.9%) | 39(70.9%)b | 15(27.3%)b | 16(29.1%)b | 3(5.5%)b | 13(23.6%)b | 8(14.5%) b | 5(9.1%)b | 10(18.2%)b |
| | 14(51.9%)a | 19(67.9%)c | 8(28.6%)c | 10(35.7%)c | 5(17.9%)c | 5(17.9%)c | 4(14.3%)c | 1(3,6%)c | 3(10.7%)c |
amissing = 3, bmissing = 1, cmissing = 2, dn = 85
CHF Chronic Heart Failure, COPD Chronic Obstructive Pulmonary Disease
Meaningful use per patient characteristic and reports of odds ratios n = 86
| OR (95% CI) | P-value | AUC | |
|---|---|---|---|
| COPD | 2.2 (0.8 -6.0) | .11 | 0.60 |
| Living alone | 1.2 (0.5 -3.1) | .67 | 0.52 |
| Women | 1.6 (0.6 -3.9) | .34 | 0.56 |
| Technical skills rated as poor | 0.8 (0.3 -2.0) | .62 | 0.53 |
| Education/level | 0.7 (0.5 -1.1) | .087 | 0.61 |
| Age/5 year | 0.9 (0.7 -1.2) | .58 | 0.55 |
| COPD | 1.9 (0.7 -5.1) | .22 | 0,58 |
| Living alone | 2.2 (0.8 -6.2) | .12 | 0,59 |
| Women | 1.8 (0.7 -4.7) | .24 | 0,57 |
| Technical skills rated as poor | 1.3 (0.5 -3.3) | .65 | 0,53 |
| Education/level | 0.8 (0,5 -1,1) | .19 | 0,59 |
| Age/5 year | 0.9 (0.7 -1.2) | .59 | 0,54 |
| COPD | 1.0 (0.4 -2.7) | .99 | 0,50 |
| Living alone | 1.9 (0.7 -5.0) | .20 | 0,58 |
| Women | 3.9 (1.4 -11.1) | .009 | 0,66 |
| Technical skills rated as poor | 3.4 (1.2 -9.1) | .017 | 0,65 |
| Education/level | 1.0 (0.6 -1.5) | .85 | 0,51 |
| Age/5 year | 1.0 (0.8 -1.3) | .90 | 0,49 |
| COPD | 3.5 (1.03 -11.9) | .045 | 0,64 |
| Living alone | 2.9 (0.98 -8.4) | .055 | 0,63 |
| Women | 2.2 (0.8 -6.4) | .15 | 0,60 |
| Technical skills rated as poor | 0.7 (0.2 -2.1) | .53 | 0,54 |
| Education/level | 0.8 (0.5 -1.2) | .26 | 0,58 |
| Age/5 year | 1 (0.8 -1.4) | .76 | 0,50 |
| COPD | 1.6 (0.6 -4.2) | .36 | 0,56 |
| Living alone | 3.5 (1.3 -9.1) | .012 | 0,65 |
| Women | 1 (0.4 -2.6) | .96 | 0,50 |
| Technical skills rated as poor | 1.2 (0.5 -3) | .75 | 0,52 |
| Education/level | 1.1 (0.7 -1.6) | .69 | 0,53 |
| Age/5 year | 1 (0.8 -1.3) | .84 | 0,53 |
AUC area under the ROC curve, CI confidence interval, OR odds ratio
Predictors included in the multiple regression-models most likely to explain meaningful use, n = 79
| Predictors per intervention function | Adjusted OR (95% CI) | AUC | ||
|---|---|---|---|---|
| Intervention function | Predictor | |||
| Rating technical competence as poor | .014 | 3.6 (1.3–10.0) | 0.65 | |
| Diagnosis of COPD | .045 | 3.5 (1,03–11,9) | 0.64 | |
| Living alone | .044 | 2.8 (1.03–7.4) | 0.62 | |
AUC area under the ROC curve, CI confidence interval, OR odds ratio
Overview of the categories and sub-categories by meaningful and non-meaningful use
| Non-meaningful usea | Meaningful usea | |||
|---|---|---|---|---|
| Not in need | Deficiency in communication | Benefits in everyday life | A personal boost | |
| Health under control | Issues with technology inhibits contact | Feeling safe and secure | Being met with a personal commitment | |
| Adequate care support | Lacking personal contact | Flexible use of time and reduced stress | Seeing what I need and want | |
| Unexpressed aims and expectations | Measure of health | Setting a common course of action | ||
| Finding strength for the next step | ||||
aOverall rating of the remote PCC intervention as meaningful to use dichotomised into yes and no answers